Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Ixabepilone by R-Pharm US for Fallopian Tube Cancer: Likelihood of Approval
Ixabepilone is under clinical development by R-Pharm US and currently in Phase II for Fallopian Tube Cancer. According to GlobalData,...
Ixabepilone by R-Pharm US for Peritoneal Cancer: Likelihood of Approval
Ixabepilone is under clinical development by R-Pharm US and currently in Phase II for Peritoneal Cancer. According to GlobalData, Phase...
Ixabepilone by R-Pharm US for Epithelial Ovarian Cancer: Likelihood of Approval
Ixabepilone is under clinical development by R-Pharm US and currently in Phase II for Epithelial Ovarian Cancer. According to GlobalData,...